Pace Life Sciences LLC, a U.S.-based contract research, development, and manufacturing organization (CRDMO) and a Division of ...

According to CEO: ‘Demand across the industry not meeting our expectations.’ ...

In 2024, AI was one of the hottest topics, affecting every corner of nearly every industry. It has continued to become deeply ...

The U.S. Food and Drug Administration (FDA) has approved Celltrion’s AVTOZMA (CT-P47, tocilizumab-anoh) in both an ...

Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing cutaneous ...

Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics, has opened its Center of Excellence for ...

ICON plc, a clinical research organization, expanded its portfolio of artificial intelligence (AI) tools that aim to deliver efficiencies across the clinical trial process, including study startup, ...

Gilead is expected to enhance its efficiency through leveraging Cognizant’s expertise in AI and advanced technology ...

Schrödinger, a global leader in computational chemistry, has adopted the Sapio Sciences Platform to improve data management, ...

InstantGMP, a leader in fully integrated GMP-compliant software solutions for pharmaceutical manufacturing, has partnered ...

Amit founded Pharmanovia (previously Atnahs) in 2013. He was formerly the CEO and now plays a critical role as Executive Lead ...

The approval is based on results from the Phase III FLOW trial demonstrating Ozempic reduced the risk of severe kidney outcomes by 24% compared to placebo, including kidney failure, reduction in ...